eFFECTOR Therapeutics- Warrants (26/08/2026) Current Cash

As of the most recent data (June 2026), EFTRW shows a current cash of $470K. That compares with $1.1M in the prior-year period — down 58.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EFTRW's current cash is now $470K (was $1.1M) — a 58.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether eFFECTOR Therapeutics- Warrants (26/08/2026) is outperforming or lagging.

Tracking EFTRW's current cash over time shows whether eFFECTOR Therapeutics- Warrants (26/08/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $470K That compares with $1.1M in the prior-year period — down 58.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has eFFECTOR Therapeutics- Warrants (26/08/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $470K) with ownership activity and broader fundamentals.

eFFECTOR Therapeutics- Warrants (26/08/2026)'s current cash is $470K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.